Organization | International Center for Diarrheal Disease Research

International Center for Diarrheal Disease Research Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Dhaka Bangladesh (1960)

Organization Overview

First Clinical Trial

1993

NCT00374023

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Assistant Scientist | Assistant Scientist, Infectious Diseases Division, icddr,b | Centre for Vaccine Sciences, International Centre for Diarrhoeal Disease Research, Bangladesh | Chief Physician and Head, Hospitals, icddr,b | ICCDR,B | ICDDR,B: Centre for Health and Population Research | ICDDR,B: Centre for Health & Population Research | International Center for Diarrheal Disease Research, Bangladesh | International Center for Diarrhoeal Disease Research, Bangladesh | International Centre for Diarrhoeal Disease Research b | International Centre for Diarrhoeal Disease Research, Bangladesh | International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Child and Adolescent Health | International Centre for Diarrhoel Disease Research, Bangladesh | International Centre for Diiarrhoeal Disease Research, Bangladesh | Research Fellow, Nutrition & Clinical Services Division, icddr,b | Research Investigator,NCSD, icddr,b | Research Investigator, Nutrition and Clinical Services Division, icddr,b | Senior Director, Nutrition & Clinical Services Division, icddr,b | The International Centre for Diarrhoeal Disease Research, Bangladesh

Active Ingredients

Drugs in Phase 4 Trials (26)

bivalent oral polio vaccine (bopv), type 1 and type 3 (9 trials)

chloroquine (1 trial)

coartem (1 trial)

f-ipv (1 trial)

hecolin (1 trial)

hepatitis b vaccine (recombinant) (recombivax) (2 trials)

human rotavirus, live attenuated (Rotarix) (4 trials)

inactivated influenza vaccine (2 trials)

ipv (11 trials)

iron (3 trials)

je-vax (1 trial)

live attenuated sa 14-14-2 vaccine (1 trial)

live oral poliovirus type 1, 2 and 3 (3 trials)

lumefantrine (Coartem) (1 trial)

mcv-ac vaccine group (1 trial)

measles-rubella vaccine (2 trials)

mifepristone (mifeprex) (1 trial)

miltefosine (impavido) (3 trials)

misoprostol (cytotec) (1 trial)

monovalent oral polio vaccines (mopv1) (1 trial)

monovalent oral polio vaccines (mopv2) (2 trials)

poliovirus vaccine inactivated (2 trials)

primaquine (2 trials)

sa-14-14-2 (1 trial)

vi-dt typhoid conjugate vaccine (1 trial)

zn2+ (9 trials)

Drugs in Phase 3 Trials (35)

allogeneic blood cells (1 trial)

amphotericin b (fungizone) (2 trials)

azithromycin (zithromax) (9 trials)

bivalent opv (1 trial)

cecolin (1 trial)

chickpea (2 trials)

ciprofloxacin (cipro) (2 trials)

dopamine (intropin) (1 trial)

engerix-b (1 trial)

epinephrine (levophed) (1 trial)

human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (2 trials)

hydroxocobalamin (cyanokit) (1 trial)

inactivated sabin strain polio virus (1 trial)

killed oral cholera vaccine (3 trials)

live attenuated influenza virus vaccine (flumist) (2 trials)

menacwy conjugate vaccine (1 trial)

molasses (1 trial)

moringa (1 trial)

oseltamivir (tamiflu) (1 trial)

pancrelipase (creon) (1 trial)

paromomycin (humatin) (2 trials)

polio, inactivated poliovirus vaccine (salk) (1 trial)

resistant starch (1 trial)

roasted lentil (1 trial)

roasted rice (1 trial)

shanchol (5 trials)

soybean (2 trials)

soybean oil (1 trial)

ursodeoxycholic acid (1 trial)

vitamin a (7 trials)

vitamin d3 (7 trials)

whole wheat allergenic extract (1 trial)

zinc dichloride (6 trials)

Drugs in Phase 2 Trials (30)

albendazole (Albenza) (4 trials)

anx005 (1 trial)

arsenic (1 trial)

artesunate (3 trials)

azd1222 (1 trial)

bifidobacterium infantis (2 trials)

ceftriaxone (rocephin) (1 trial)

cholvax (1 trial)

covid-19 vaccine (vero cells) (1 trial)

doxycycline (vibramycin) (2 trials)

etec vaccine (1 trial)

ev71 vaccine (1 trial)

fiber (1 trial)

heat stable rotavirus vaccine (1 trial)

immune globulin (human) (1 trial)

iowh032 (2 trials)

ivermectin (stromectol) (1 trial)

lacto-n-tetraose (1 trial)

llama-derived anti-rotavirus vhh fragment (1 trial)

nbp615 (1 trial)

novel monovalent oral poliovirus vaccine type 2 (2 trials)

peru-15-pctb (1 trial)

secnidazole (solosec) (1 trial)

sodium bicarbonate (1 trial)

sodium butyrate (1 trial)

sodium chloride (1 trial)

sodium phenylbutyrate (buphenyl) (1 trial)

tebipenem (1 trial)

tv005 (1 trial)

Drugs in Phase 1 Trials (10)

calcium (2 trials)

calcium carbonate (2 trials)

ferric fumarate (1 trial)

ferric pyrophosphate citrate (triferic) (1 trial)

fish surimi peptide (1 trial)

inulin (1 trial)

pneumococcal protein vaccine (1 trial)

rabix-vc (1 trial)

typbar-tcv vaccine (1 trial)

wrss1 (2 trials)

Drugs in Other Trials (31)

13c10-retinyl-acetate (1 trial)

amoxicillin (1 trial)

cobalamin (1 trial)

cow milk (2 trials)

ferrous sulfate (1 trial)

green banana flour (1 trial)

haemophilus b conjugate vaccine diphteria crm197 protein conjugate (Menveo) (1 trial)

hepatitis a vaccine, inactivated (vaqta) (1 trial)

high-selenium lentils (1 trial)

high-selenium yeast (1 trial)

human milk (1 trial)

lactobacillus reuteri (1 trial)

lentils (1 trial)

levocarnitine (carnitor) (1 trial)

lysine (1 trial)

methylcobalamin (1 trial)

niacin (1 trial)

nitazoxanide (alinia) (1 trial)

probiotic (1 trial)

ptm202 (1 trial)

pyrequan (1 trial)

pyridoxine (1 trial)

quinine (qualaquin) (1 trial)

sodium dichloroisocyanurate (1 trial)

sweet potato (1 trial)

thiamine (1 trial)

vitamin c (1 trial)

vitamin e (1 trial)

zinc sulfate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anemia (Phase 3)

Anemia, Iron-Deficiency (Phase 3)

Birth Weight (Phase 1)

Bronchiolitis (Phase 3)

Cachexia (Phase 3)

Campylobacter Infections (Phase 3)

Child Nutrition Disorders (Phase 3)

Cholera (Phase 3)

Communicable Diseases (Phase 3)

Death (Phase 3)

Dengue (Phase 2)

Diarrhea (Phase 4)

Dysentery, Bacillary (Phase 3)

Encephalitis (Phase 4)

Encephalitis, Japanese (Phase 4)

Fever (Phase 1)

Foot-and-Mouth Disease (Phase 2)

Gastroenteritis (Phase 4)

Growth Disorders (Phase 3)

Guillain-Barre Syndrome (Phase 2)

Hand, Foot and Mouth Disease (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 3)

Hepatitis E (Phase 4)

Infections (Phase 4)

Influenza, Human (Phase 3)

Intestinal Diseases (Phase 3)

Kwashiorkor (Phase 3)

Leishmaniasis (Phase 4)

Leishmaniasis, Visceral (Phase 4)

Malaria (Phase 4)

Malaria, Falciparum (Phase 2)

Malnutrition (Phase 3)

Maternal Death (Phase 3)

Measles (Phase 4)

Mouth Diseases (Phase 2)

Neonatal Sepsis (Phase 3)

Night Blindness (Phase 3)

Perinatal Death (Phase 3)

Pneumonia (Phase 3)

Poliomyelitis (Phase 4)

Pregnancy Complications, Infectious (Phase 3)

Puerperal Infection (Phase 3)

Respiratory Tract Infections (Phase 3)

Rotavirus Infections (Phase 4)

Rubella (Phase 4)

Rubella Syndrome, Congenital (Phase 4)

Sepsis (Phase 3)

Severe Acute Malnutrition (Phase 3)

Sprue, Tropical (Phase 3)

Syndrome (Phase 2)

Thinness (Phase 3)

Toxemia (Phase 3)

Tuberculosis (Phase 2)

Tuberculosis, Pulmonary (Phase 2)

Typhoid Fever (Phase 2)

Uterine Cervical Neoplasms (Phase 3)

Vibrio Infections (Phase 2)

Virus Diseases (Phase 3)

Vitamin A Deficiency (Phase 3)

Wasting Syndrome (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 143
# of Trial APIs: 132